Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients
Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment; however, a significant proportion of gastric cancer (GC) patients do not respond to this therapy. Consequently, there is an urgent need to elucidate the mechanisms underlying resistance to ICIs and identify robust...
Saved in:
Main Authors: | Jiangang Sun (Author), Xiaojing Li (Author), Qian Wang (Author), Peng Chen (Author), Longfei Zhao (Author), Yongshun Gao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients
by: Su Yin Lim, et al.
Published: (2017) -
The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile
by: Eng Alvin KH, et al.
Published: (2008) -
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
by: Rilan Bai, et al.
Published: (2020) -
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
by: Jinhua Liu, et al.
Published: (2021) -
Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer
by: Xin Qiu, et al.
Published: (2023)